Literature DB >> 22287125

Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model.

Chang-Moon Lee1, Doorye Jang, Su-Jin Cheong, Min-Hee Jeong, Eun-Mi Kim, Dong Wook Kim, Seok Tae Lim, Myung-Hee Sohn, Hwan-Jeong Jeong.   

Abstract

The purpose of this study was to use a near-infrared (NIR) fluorescent cyclic His-Try-Gly-Phe peptide to characterize and image the expressions of matrix metalloproteinases (MMPs), which are correlated with cancer promotion, in an inflammation-induced colorectal cancer (ICRC) model. We explored the relationship between the development of colon cancer and the expression of MMPs at the same colonic sites in ICRC models. To develop ICRC models, mice were administered a single intraperitoneal dose (10 mg/kg) of azoxymethane (AOM) and exposed orally to 2% dextran sodium sulfate (DSS) for one week. MMP-2 expression and β-catenin activation in colonic lesions were characterized by immunohistochemical (IHC) staining. After being treated with inducers for some time, cancerous lesions were found to express high β-catenin and MMP-2. The profiles of MMP expression were correlated with β-catenin activation in the colonic lesions. c(KAHWGFTLD)NH(2) (C6) peptide was prepared by standard Fmoc peptide synthesis to target MMPs. Molecular weight of Cy5.5-C6 was 1,954.78 g/mol (calculated MW = 1955.23 g/mol). The in vitro characterization of Cy5.5-C6 showed MMP binding specificity in a cell experiment. In vivo NIRF imaging showed high accumulation of Cy5.5-C6 in tumors with associated expression of MMP-2 in colonic lesions after intravenous injection. The MMP-2 specificity of Cy5.5-C6 was confirmed by successful inhibition of probe uptake in the tumor due to the presence of excess C6 peptide. The use of Cy5.5-C6 to target MMP-2 has the potential to be developed into an effective molecular imaging agent to monitor ICRC progress.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287125     DOI: 10.1002/ijc.27451

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis.

Authors:  Tareq Anani; Peter Panizzi; Allan E David
Journal:  Nanomedicine (Lond)       Date:  2016-07-28       Impact factor: 5.307

Review 2.  Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology.

Authors:  Chongwei Chi; Yang Du; Jinzuo Ye; Deqiang Kou; Jingdan Qiu; Jiandong Wang; Jie Tian; Xiaoyuan Chen
Journal:  Theranostics       Date:  2014-08-15       Impact factor: 11.556

3.  Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.

Authors:  Qinghua Liu; Donghui Pan; Chao Cheng; Dazhi Zhang; Anyu Zhang; Lizhen Wang; Hongdie Jiang; Tao Wang; Hongrui Liu; Yuping Xu; Runlin Yang; Fei Chen; Min Yang; Changjing Zuo
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 4.  Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field.

Authors:  Xiaomin Yi; Fuli Wang; Weijun Qin; Xiaojian Yang; Jianlin Yuan
Journal:  Int J Nanomedicine       Date:  2014-03-05

Review 5.  Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.

Authors:  Michal Stawarski; Marzena Stefaniuk; Jakub Wlodarczyk
Journal:  Front Neuroanat       Date:  2014-07-10       Impact factor: 3.856

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.